Tag Archives: NECC

FDA Already Knew of Problems at New England Compounding Center

By Guest Blogger | Published: November 14, 2012
By Amy Ritter. In the wake of the meningitis outbreak caused by contaminated compounded medications produced by the New England Compounding Center (NECC), both the government and the public have been wrestling with the question of how this happened — how did a company producing substandard medicines slip through regulatory oversight?
Posted in Guest Blog, Regulatory | Also tagged , , | Leave a comment

Compounded Drug Crisis Spotlights Regulatory Confusion

By Guest Blogger | Published: October 9, 2012
Compounded drug crisis spotlights regulatory confusion The call for stiffer FDA regulation of compounded drugs has been reignited by a national fungal meningitis outbreak. Last week, the Centers for Disease Control and Prevention (CDC) reported 7 deaths linked to contaminated vials of steroid injectables from a Massachusetts compounding operation. 91 people have been taken ill, with [...]
Posted in FDA, Op-Ed, Safety | Also tagged , , , | Leave a comment